Table 3 The mean (± standard deviation) foveal thickness (μm) at various points after the first injection in each treatment schedule group
Treatment schedule | ||||
|---|---|---|---|---|
During the third year | Baseline | 1 year | 2 years | 3 years |
All eyes (n = 128) | 338 (127) | 206 (69) | 212 (62) | 212 (55) |
As-needed injections determined by quarterly examination schedule | ||||
(n = 28) | 349 (154) | 206 (60) | 190 (39) | 216 (41) |
As-needed injections determined by monthly examination schedule | ||||
(n = 61) | 303 (120) | 201 (73) | 200 (65) | 198 (53) |
Monthly injection schedule (n = 18) | 380 (122) | 214 (72) | 255 (49) | 231 (48) |
Treat-and-extend schedule (n = 21) | 377 (73) | 213 (70) | 239 (68) | 225 (73) |